In last trading session, Kronos Bio Inc (NASDAQ:KRON) saw 1.97 million shares changing hands with its beta currently measuring 1.67. Company’s recent per share price level of $0.70 trading at -$0.03 or -2.76% at ring of the bell on the day assigns it a market valuation of $42.98M. That closing price of KRON’s stock is at a discount of -128.57% from its 52-week high price of $1.60 and is indicating a premium of 4.29% from its 52-week low price of $0.67.
For Kronos Bio Inc (KRON), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 3.00. Splitting up the data highlights that, out of 4 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 4 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Kronos Bio Inc (NASDAQ:KRON) trade information
Upright in the red during last session for losing -2.76%, in the last five days KRON remained trading in the red while hitting it’s week-highest on Tuesday, 05/13/25 when the stock touched $0.70 price level, adding 5.99% to its value on the day. Kronos Bio Inc’s shares saw a change of -25.79% in year-to-date performance and have moved -3.40% in past 5-day. Kronos Bio Inc (NASDAQ:KRON) showed a performance of -18.78% in past 30-days.
Wall Street analysts have assigned a consensus price target of 1.62 to the stock, which implies a rise of 56.92% to its current value. Analysts have been projecting 1 as a low price target for the stock while placing it at a high target of 2.25. It follows that stock’s current price would drop -42.86% in reaching the projected high whereas dropping to the targeted low would mean a loss of -42.86% for stock’s current value.
Kronos Bio Inc (NASDAQ:KRON)’s Major holders
VIDA VENTURES ADVISORS, LLC is the top institutional holder at KRON for having 2.77 million shares of worth $3.43 million. And as of 2024-06-30, it was holding 4.6012 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 1.92 million shares on 2024-06-30. The number of shares represents firm’s hold over 3.1994 of outstanding shares, having a total worth of $2.38 million.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024, the former fund manager was holding 1.32 shares of worth $0.93 million or 2.16% of the total outstanding shares. The later fund manager was in possession of 559.54 shares on Dec 31, 2024, making its stake of worth around $0.39 million in the company or a holder of 0.92% of company’s stock.
